Healthcare

Trends in Nanomedicine (TechVision)

Nano-based science paving the precision medicine era

INDUSTRY
Healthcare

RELEASE DATE
30-Dec-2015
REGION
Global
DELIVERABLE TYPE
Technology Research

RESEARCH CODE
D6C0-01-00-00-00
SKU
HC02409-GL-TR_16531
Yes
SHARE

Trends in Nanomedicine (TechVision)
Published on: 30-Dec-2015 | SKU: HC02409-GL-TR_16531

Need more details?

$4,950.00

$3,712.50 save 25 %

DownloadLink
Need more details?

The continued development of new treatments associated with the demographic trends and public health considerations is remarkable. Nanotechnology has been identified as one most relevant key enabling technologies of the last ten years, significantly impacting on many different biomedical developments in a broad spectrum of applications therapeutics, diagnostics, theranostics, medical imaging, regenerative medicine, life sciences research and biosciences, among many others. In fact, nanomedicine is present in all therapeutic areas, exhibiting a perceptible and extensive impact in the treatment and diagnosis of some most concerned diseases.

Innovation in nanomedicine fields has played a major role in the improvement of both length and quality of life during the present decade, appreciably advocated to reduce the disease burden for individuals and the society through completely new or improved diagnostic and therapeutic methods. Groundbreaking advances in the scientific understanding of the underlying mechanisms of disease are paving the way for nanomedicine on precision medicine topics.

Frost & Sullivan (www.frost.com/techvision) identified an unprecedented behavior in terms of innovation in nanomedicine fields, with notable acceptance in diagnostics, therapeutics, companion diagnostics, regenerative medicine, and many other applications that are undoubtedly linked to the concept of precision medicine. Nanomedicine enables personalized medicine approaches in many ways. As an instance, nano-based diagnostic tests or nano-imaging diagnosis may help to the stratification of patients and thereby to guarantee a most personalized, patient-centered therapy. In addition, clinical protocols become simpler, more efficient and less costly.

Research Scope

Research Scope (continued)

Research Methodology

Key Findings

Industry Value Chain and Business Model

Core Technology Applications

Technology Evolution

Core Growth Opportunities

Technology Synergy and Nanobiotechnology

Technology Roadmap

Industry Drivers and Restraints

Industry Technical and Business Challenges

Market Drivers and Restraints

Technology Drivers and Restraints

Porter’s Five Forces Analysis

Nanomedicine Innovation Model

Nanomedicine Innovation Model (continued)

Nanomedicine Innovation Model (continued)

Nanomedicines Application Focus

Nanomedicines Therapeutics Focus

Nanomedicines Diagnostics Focus

Nanomedicines Regenerative Medicine Focus

Nanomedicine Multiple Segmentation

Nanomedicines Principal Industry Facts

Nanomedicines Principal Industry Facts (continued)

Nanomedicine Development Pipeline

Nanomedicine Products by Developmental Phase

Global Nanomedicine Market

Global Nanomedicine Market (continued)

Global Nanomedicine Market (continued)

Product Pipeline

Product Pipeline (continued)

Product Pipeline (continued)

Product Pipeline (continued)

Product Pipeline (continued)

Product Pipeline (continued)

Nanomedicine Marketed Products

Nanomedicine Marketed Products (continued)

Nanomedicine Marketed Products (continued)

Key Companies in North America

Key Companies in North America (continued)

Key Companies in North America (continued)

Key Companies in North America (continued)

Key Companies in North America (continued)

Key Companies in North America (continued)

Key Companies in North America (continued)

Key Companies in North America (continued)

Key Companies in North America (continued)

Key Companies in North America (continued)

Key Companies in North America (continued)

Key Companies in North America (continued)

Key Companies in North America (continued)

Key Companies in North America (continued)

Key Companies in North America (continued)

Key Companies in North America (continued)

Key Companies in Europe

Key Companies in Europe (continued)

Key Companies in Europe (continued)

Key Companies in Europe (continued)

Key Companies in Europe (continued)

Key Companies in Europe (continued)

Key Companies in Europe (continued)

Key Companies in Asia Pacific

Key Companies in Asia Pacific (continued)

Intellectual Property

Intellectual Property (continued)

Intellectual Property (continued)

Multicriteria Approach for Benchmarking

Multicriteria Approach for Benchmarking (continued)

Multicriteria Approach for Benchmarking (continued)

Multicriteria Approach for Benchmarking (continued)

Multicriteria Approach for Benchmarking (continued)

Multicriteria Approach for Benchmarking (continued)

Multicriteria Approach for Benchmarking (continued)

Multicriteria Approach for Benchmarking (continued)

Multicriteria Approach for Benchmarking (continued)

Final Remarks

Legal Disclaimer

Key Contacts

Key Contacts (continued)

Key Contacts (continued)

Key Contacts (continued)

Key Contacts (continued)

Key Contacts (continued)

Key Contacts (continued)

Intellectual Property Sources

Key Patents

Key Patents (continued)

Key Patents (continued)

The Frost & Sullivan Story

Value Proposition: Future of Your Company & Career

Global Perspective

Industry Convergence

360º Research Perspective

Implementation Excellence

Our Blue Ocean Strategy


Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.

Recent related Healthcare research

16 Nov 2026   |   North America   |   Frost Radar

Frost Radar™: Healthcare Data Interoperability Platforms and Integration Engines in North America, 2026

This Frost Radar™ analyzes the healthcare data platform and integration engine vendors that enable healthcare organization to improve the exchange, utilization, contextualization, and management of clinical, operational, financial, and administrative data. Data issues, AI adoption, and solution gove...

03 Nov 2026   |   North America   |   Market Research

Enterprise Imaging Market, United States, 2025–2030

Enterprise imaging is no longer a technology upgrade. It is becoming the operating model for imaging across the provider organization, and the next investment cycle will decide which vendors lead it. This study gives vendors, ecosystem partners, and provider leaders a 360-degree view of that shift, ...

02 Nov 2026   |   Global   |   Market Research

Continuous Glucose Monitoring Market, Global, 2026

The global continuous glucose monitoring (CGM) market is undergoing a fundamental transformation as the technology evolves from a prescription-led glucose monitoring device into an AI-connected metabolic intelligence ecosystem. Market expansion is increasingly driven by the emergence of over-the-cou...

28 Oct 2026   |   Global   |   Frost Radar

Frost Radar™: Health Monitoring Wearable Solutions, 2026

The health monitoring wearables industry is undergoing a profound transformation as competitive advantage shifts from device hardware to integrated digital health ecosystems. Market leaders are differentiating through clinically validated health insights, longitudinal data platforms, AI-enabled anal...

26 Oct 2026   |   Global   |   Technology Research

Game-Changing Innovations Transforming Cardiovascular Care

The study analyzes game-changing technologies transforming cardiovascular care across diagnosis, image-guided intervention, functional assessment, clinical workflow, and longitudinal patient monitoring. The analysis covers five segments: diagnostic imaging and AI-enabled cardiac assessment; interve...

 

Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.